Raben David sold BCAX
March 3, 2026 · Form 4 insider transaction
Raben David sold 200 shares of Bicara Therapeutics Inc. at $18.45 per share, a transaction worth $3.7K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
200
Price
$18.45
Total value
$3.7K
InsiderRaben David
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateMarch 3, 2026
Filing dateMarch 5, 2026
Shares owned after55,286
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025.